Insider Shareholders with Direct Ownership of Protagonist Therapeutics, Inc (PTGX)
This section provides a comprehensive overview of the insiders with direct ownership of Protagonist Therapeutics, Inc (PTGX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Protagonist Therapeutics, Inc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Canaan X L.P.
> 10% Shareholder |
0 | 336,703 | 2,116,552 $101 Million | 13 |
May 17, 2018
Reduced 1.81%
|
|
Dinesh V Ph D Patel
President and CEO |
329,954 | 253,407 | 514,415 $24.5 Million | 25 |
Jun 13, 2024
Reduced 0.19%
|
|
Suneel Gupta
Chief Development Officer |
141,375 | 14,081 | 183,285 $8.73 Million | 12 |
Feb 26, 2024
Reduced 2.28%
|
|
David Y Liu
Chief R&D Strategy Officer |
130,479 | 16,898 | 167,590 $7.98 Million | 6 |
Nov 16, 2022
Added 17.41%
|
|
Arturo Md Molina
Chief Medical Officer |
50,625 | 2,275 | 48,350 $2.3 Million | 5 |
Jan 16, 2024
Reduced 0.88%
|
|
Asif Ali
Chief Financial Officer |
81,375 | 46,415 | 34,960 $1.66 Million | 13 |
Sep 11, 2024
Reduced 25.55%
|
|
Harold E Selick
Director |
12,686 | 0 | 27,996 $1.33 Million | 2 |
Mar 07, 2024
Added 18.82%
|
|
Donald A. Kalkofen
Chief Financial Officer |
15,000 | 0 | 18,521 $881,970 | 2 |
Feb 15, 2022
Added 28.82%
|
|
Samuel R Saks
Chief Medical Officer |
12,000 | 0 | 14,000 $666,680 | 1 |
Feb 26, 2021
Added 46.15%
|
|
William D. Waddill
Director |
48,975 | 36,975 | 12,000 $571,440 | 9 |
Sep 10, 2024
Reduced 40.0%
|
|
Sarah B. Noonberg
Director |
8,400 | 8,400 | 0 $0 | 4 |
Feb 11, 2021
Reduced 100.0%
|